Importantly, comparing WT mice with IL-6 KO mice, both treated with the combination of gDE7 + IDO inhibitors, we observed a significantly decreased in tumor growth in IL-6 defective mice, especially when treated with D-1MT (Supplementary Figure S1). This evidence concerns the gene IDO1 and neoplasm.